Lifeway Foods Inc

Lifeway Foods Inc(LWAY)股票分析

$22.460

-0.451 (-2.01%)收盤時

Loading chart…
最高
23.000
開盤
22.860
成交量加權均價
22.60
成交量
78.33K
市值
183.99M
最低
22.350
成交金額
1.77M
企業價值/稅息折舊攤銷前利潤(TTM)
51.98

Lifeway Foods, Inc. is a supplier of the probiotic, fermented beverage known as Kefir. In addition to its line of drinkable Kefir, the Company also produces a variety of cheeses and a ProBugs line for kids. Its primary product is drinkable kefir, a cultured dairy product. Lifeway kefir is tart and tangy, high in protein, calcium and vitamin D. It manufactures products under the Lifeway, Fresh Made and GlenOaks Farms brand names, as well as under private labels on behalf of certain customers. Its product categories are Drinkable kefir; European-style soft cheeses, including farmer cheese, white cheese, and Sweet Kiss; Cream and others, which consist primarily of cream, a byproduct of making its kefir; Drinkable yogurt, sold in a variety of sizes and flavors; ProBugs, a line of kefir products designed for children, and Other dairy, which consists primarily of Fresh Made butter and sour cream.

AI 分析 of Lifeway Foods Inc (LWAY)

持有

Lifeway Foods Inc is currently a hold. The stock is priced at $22.46, with a forward P/E of 29.94, which indicates potential for growth but also suggests it may be overvalued based on earnings. The recent sell-offs by major shareholders, including a 20,000 share sale, have raised concerns about investor confidence, which could pressure the stock in the short term. However, the company reported a record Q2 sales growth of 24.1%, indicating strong demand for its products. The main risk is the declining gross margin, which fell to 19.27% in Q2 due to rising costs, impacting profitability.

分析師評級(1)

上檔空間 +55.83%
買進
1 買進
0 持有
0 賣出
目前: 22.46
最低
35.00
平均
35.00
最高
35.00

BTIG

2026-08-20

目標價

$32

買進

Freedom Broker

2026-05-15

目標價

$34

持有

Benchmark

2025-11-13

目標價

$35

買進

Lake Street

2025-08-13

目標價

$33

買進

Noble Capital Markets

2024-09-24

目標價

—

持有

估值指標

Lifeway Foods Inc(LWAY)目前預期本益比為 29.94,5 年平均預期本益比為 25.26。

預期本益比

合理
5 年均值 P/E
25.26
目前P/E
29.94
高估
42.79
低估
7.72

預期 EV/EBITDA

高估
5 年均值 EV/EBITDA
10.96
目前EV/EBITDA
51.98
高估
33.11
低估
-11.18

預期股價營收比

合理
5 年均值 P/S
1.10
目前P/S
1.16
高估
1.62
低估
0.58

Alphio AI 對 LWAY 的價格情境

情境價格取自當年最後一個月度預測區間。機率為固定的模型權重(25 / 50 / 25),不構成保證。

樂

樂觀

樂觀 · 25%LWAY

$22.63

情境價格

基

基準

基準 · 50%LWAY

$20.77

情境價格

悲

悲觀

悲觀 · 25%LWAY

$19.20

情境價格

持有 LWAY 的大戶

D

Divisadero Street Capital Management, LP

+ 持有LWAY

-11.75%

3個月報酬率

事件時間軸

2026-08-13 (ET)

09:30:00

Lifeway Reports Q2 Revenue of $66.9M, Highest in Company History

2026-04-01 (ET)

09:10:00

Lifeway Foods Expects Q1 2026 Net Sales of $60.8M to $62.3M

2026-03-17 (ET)

09:20:00

Lifeway Foods Q4 Revenue Reaches $55.361M

2025-12-19 (ET)

10:40:00

Lifeway Foods Shareholder Raises Governance Concerns

2025-12-03 (ET)

08:30:00

Lifeway Foods Shareholder Responds to Board's False Claims

資訊

LWAY 常見問題 —— 由 Alphio AI 解答

Lifeway Foods, Inc. is a supplier of the probiotic, fermented beverage known as Kefir. In addition to its line of drinkable Kefir, the Company also produces a variety of cheeses and a ProBugs line for kids. Its primary product is drinkable kefir, a cultured dairy product. Lifeway kefir is tart and tangy, high in protein, calcium and vitamin D. It manufactures products under the Lifeway, Fresh Made and GlenOaks Farms brand names, as well as under private labels on behalf of certain customers. Its product categories are Drinkable kefir; European-style soft cheeses, including farmer cheese, white cheese, and Sweet Kiss; Cream and others, which consist primarily of cream, a byproduct of making its kefir; Drinkable yogurt, sold in a variety of sizes and flavors; ProBugs, a line of kefir products designed for children, and Other dairy, which consists primarily of Fresh Made butter and sour cream. It operates in the Consumer Non-Cyclicals sector (DAIRY PRODUCTS industry).

Lifeway Foods Inc is currently a hold. The stock is priced at $22.46, with a forward P/E of 29.94, which indicates potential for growth but also suggests it may be overvalued based on earnings. The recent sell-offs by major shareholders, including a 20,000 share sale, have raised concerns about investor confidence, which could pressure the stock in the short term. However, the company reported a record Q2 sales growth of 24.1%, indicating strong demand for its products. The main risk is the declining gross margin, which fell to 19.27% in Q2 due to rising costs, impacting profitability.

1 analysts cover LWAY: 1 rate it Buy, 0 Hold and 0 Sell. The average price target is 35.00.

暫無貼文

註冊或登入後參與討論

本頁僅供研究參考,不構成投資建議。模型可能出錯。過往表現不代表未來結果。

開始交易